Key facts
- This page summarizes John E. Gallina's Form 4 filing for Elevance Health, Inc. (ELV).
- 5 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Mar 2023, 15:15.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Tax liability
Award
Award
Tax liability
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Footnote F2
Represents restricted share units. Restrictions lapse as follows: 1,021 shares on 3/1/2024, and 1,022 shares each on 3/1/2025 and 3/1/2026.
Footnote F3
Represents performance based restricted share units. Restrictions lapse on 3/2/2023.
Footnote F4
The option represents a right to purchase a total of 11,782 shares, and is exercisable in two installments of 3,927 shares each and one installment of 3,928 shares, beginning on 3/1/2024, which is the one-year anniversary of the option grant date.